What is Leerink Partnrs’ Forecast for INSP FY2027 Earnings?

Inspire Medical Systems, Inc. (NYSE:INSP) – Leerink Partnrs cut their FY2027 EPS estimates for Inspire Medical Systems in a research report issued on Monday, November 25th. Leerink Partnrs analyst M. Kratky now anticipates that the company will earn $3.57 per share for the year, down from their previous estimate of $3.63. The consensus estimate for Inspire Medical Systems’ current full-year earnings is $1.33 per share. Leerink Partnrs also issued estimates for Inspire Medical Systems’ FY2028 earnings at $5.69 EPS.

Several other research analysts also recently weighed in on the company. Stifel Nicolaus reiterated a “hold” rating and set a $200.00 price target (up previously from $170.00) on shares of Inspire Medical Systems in a research note on Tuesday, November 5th. Leerink Partners lifted their target price on shares of Inspire Medical Systems from $167.00 to $197.00 and gave the stock a “market perform” rating in a research note on Tuesday, September 10th. Wells Fargo & Company upped their price target on shares of Inspire Medical Systems from $187.00 to $198.00 and gave the company an “equal weight” rating in a research note on Tuesday, November 5th. Royal Bank of Canada reiterated an “outperform” rating and issued a $260.00 price objective on shares of Inspire Medical Systems in a research note on Tuesday, November 5th. Finally, KeyCorp dropped their target price on Inspire Medical Systems from $278.00 to $236.00 and set an “overweight” rating on the stock in a research report on Wednesday, August 7th. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $233.58.

Inspire Medical Systems Price Performance

NYSE:INSP opened at $193.85 on Tuesday. The company has a market capitalization of $5.81 billion, a P/E ratio of 181.17 and a beta of 1.36. The business has a fifty day simple moving average of $198.72 and a two-hundred day simple moving average of $175.85. Inspire Medical Systems has a 1 year low of $123.00 and a 1 year high of $257.40.

Inspire Medical Systems (NYSE:INSP) last released its earnings results on Monday, November 4th. The company reported $0.60 earnings per share for the quarter, beating analysts’ consensus estimates of $0.06 by $0.54. The firm had revenue of $203.20 million during the quarter, compared to the consensus estimate of $197.59 million. Inspire Medical Systems had a net margin of 4.37% and a return on equity of 5.30%. The company’s revenue was up 32.6% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.29) EPS.

Institutional Trading of Inspire Medical Systems

A number of hedge funds have recently made changes to their positions in the stock. Wasatch Advisors LP lifted its position in Inspire Medical Systems by 1.6% in the 3rd quarter. Wasatch Advisors LP now owns 1,323,470 shares of the company’s stock worth $279,318,000 after buying an additional 20,481 shares during the last quarter. State Street Corp lifted its holdings in shares of Inspire Medical Systems by 78.0% in the 3rd quarter. State Street Corp now owns 1,049,784 shares of the company’s stock worth $221,557,000 after acquiring an additional 459,990 shares during the last quarter. Bank of New York Mellon Corp lifted its holdings in shares of Inspire Medical Systems by 32.3% in the 2nd quarter. Bank of New York Mellon Corp now owns 787,815 shares of the company’s stock worth $105,433,000 after acquiring an additional 192,238 shares during the last quarter. William Blair Investment Management LLC boosted its stake in shares of Inspire Medical Systems by 1.8% in the 2nd quarter. William Blair Investment Management LLC now owns 770,413 shares of the company’s stock valued at $103,104,000 after purchasing an additional 13,602 shares in the last quarter. Finally, Janus Henderson Group PLC grew its holdings in shares of Inspire Medical Systems by 5.8% during the 3rd quarter. Janus Henderson Group PLC now owns 502,609 shares of the company’s stock valued at $106,075,000 after purchasing an additional 27,374 shares during the last quarter. 94.91% of the stock is owned by institutional investors.

Insider Activity at Inspire Medical Systems

In other news, Director Shawn Mccormick sold 800 shares of the stock in a transaction on Monday, September 9th. The shares were sold at an average price of $220.00, for a total value of $176,000.00. Following the transaction, the director now owns 23,140 shares of the company’s stock, valued at $5,090,800. This represents a 3.34 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 4.10% of the stock is owned by corporate insiders.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.